Asensus Surgical Enters Agreement to Supply Senhance® System to Japanese Hospital
Medical device company, Asensus Surgical, Inc., (NYSE American: ASXC), has entered into an agreement to lease and utilize a Senhance® Surgical System to Fukuoka Tokushukai Hospital in Kasuga City, Japan.
Fukuoka Tokushukai Hospital is part of Japan’s second largest hospital system and is highly focused on delivering cutting-edge care. The hospital intends to use the Senhance® System to grow its robotic surgery capabilities and improve patient outcomes.
Highlights
Anthony Fernando, Asensus Surgical President and CEO, said, “Japan remains one of our fastest-growing regions, and we are delighted to bring another outstanding institution on board.
Dr. ”Noritomi Tomoaki, M.D., Ph.D., CEO of Fukuoka Tokushukai Hospital, said, “Senhance® is the only commercially available robotic surgery system with haptic feedback, which provides surgeons the ability to feel the tissue response of the body during a procedure.”
About Asensus Surgical
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. Based upon the foundations of Digital Laparoscopy and the Senhance® Surgical System, the Company is developing the LUNA™ Surgical System, a next generation robotic and instrument system as a foundation of its Digital Surgery solution. These systems will be powered by the Intelligent Surgical Unit to increase surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The Senhance Surgical System is now available for sale in the US, EU, Japan, Russia, and select other countries.
